PTC THERAPEUTICS, INC. — Director's Dealing 2014

Mar 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-03-19

Reporting Person: Almstead Neil Gregory (Senior VP, Research and CMC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-19	Common Stock	S	10359	$31.90	Disposed	30381	Direct
2014-03-19	Common Stock	S	500	$32.21	Disposed	29881	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1549	Indirect

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 16, 2013 for the primary purpose of covering tax obligations associated with a restricted stock vesting event.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $31.18 to $32.15 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $32.19 to $32.27 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.